Innovative Gastroesophageal Reflux Disease Treatment

GERD today is ordinarily treated with drugs, for example, histamine receptor opponents (H2 blockers), - Pepcid, Tagamet and Zantac - and with proton siphon inhibitors (PPIs) - Nexium, Prilosec and Protonic. Shockingly, these drugs can lose their viability after some time. More significantly, they don't treat the fundamental main drivers of indigestion.

    Related Conference of Innovative Gastroesophageal Reflux Disease Treatment

    November 16-17, 2020

    30th World Congress on Nursing

    Brisbane, Australia
    November 18-19, 2020

    3rd International Conference on Chemistry Education and Research

    Singapore City, Singapore
    November 23-24, 2020

    World Conference on Digestive and Metabolic Diseases

    Hanoi, Vietnam
    December 03-04, 2020

    11th International Conference on Liver Diseases & Hepatology

    Singapore City, Singapore
    December 07-08, 2020

    International Congress on Gastroenterology and Liver Transplant

    Auckland, Newzealand
    April 12-13, 2021

    16th Euro-Global Gastroenterology Conference

    London, UK
    May 07-08, 2021

    International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands

    Innovative Gastroesophageal Reflux Disease Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in